Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page
- Check5 days agoChange DetectedRevision history shows a new site release (v3.3.4) added and the previous release (v3.3.3) removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.3 was added to the Record History. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the history.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded Revision: v3.3.2 to the study record versions; removed Revision: v3.2.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a site-wide notice about government funding and operating status; the clinical trial record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check77 days agoChange DetectedThe page history lists past versions of the study record with status updates such as Study Status and Recruitment Status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded a government-operating status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference13%

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.